Human genetic disorders of sphingolipid biosynthesis. Issue 1 (21st August 2014)

• Record Type: Journal Article
• Authors: Astudillo, Leonardo; Sabourdy, Frédérique; Therville, Nicole; Bode, Heiko; Ségui, Bruno; Andrieu‐Abadie, Nathalie; Hornemann, Thorsten; Levade, Thierry
• Is Part Of: Journal of inherited metabolic disease. Volume 38:Issue 1(2015)
• Page Start: 65
• Page End: 76
• Publication Date: 2014-08-21
• Subjects: Metabolism, Inborn errors of -- Periodicals; Metabolism -- Disorders -- Periodicals; 616.39042
• DOI: 10.1007/s10545-014-9736-1
• Languages: English
• ISSNs: 0141-8955

Abstract

Abstract: Monogenic defects of sphingolipid biosynthesis have been recently identified in human patients. These enzyme deficiencies affect the synthesis of sphingolipid precursors, ceramides or complex glycosphingolipids. They are transmitted as autosomal recessive or dominant traits, and their resulting phenotypes often replicate the abnormalities seen in murine models deficient for the corresponding enzymes. In quite good agreement with the known critical roles of sphingolipids in cells from the nervous system and the epidermis, these genetic defects clinically manifest as neurological disorders, including paraplegia, epilepsy or peripheral neuropathies, or present with ichthyosis. The present review summarizes the genetic alterations, biochemical changes and clinical symptoms of this new group of inherited metabolic disorders. Hypotheses regarding the molecular pathophysiology and potential treatments of these diseases are also discussed.